Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies

scientific article published on 15 April 2019

Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.1186/S12933-019-0851-Z
P932PMC publication ID6466658
P698PubMed publication ID30987625

P50authorMohammad Ishraq ZafarQ58482963
P2093author name stringXiaofeng Ye
Lu-Lu Chen
Wen Kong
P2860cites workDiabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesQ24608301
Bias in meta-analysis detected by a simple, graphical testQ24685585
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Q27687851
Operating characteristics of a rank correlation test for publication biasQ27860653
Measuring inconsistency in meta-analysesQ27860655
Meta-analysis in clinical trialsQ27860779
Meta-analysis of Observational Studies in Epidemiology: A Proposal for ReportingQ27861077
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesQ28131633
Triglycerides and cardiovascular disease: a scientific statement from the American Heart AssociationQ28235865
10-year follow-up of intensive glucose control in type 2 diabetesQ29615973
Intensive versus moderate lipid lowering with statins after acute coronary syndromesQ29619716
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular StudyQ30979271
Hyperglycemia and cardiovascular disease in type 2 diabetesQ33637016
Hypertriglyceridemia, insulin resistance, and the metabolic syndromeQ33652030
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterolQ91501534
Molecular mechanisms of insulin resistanceQ34420707
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studiesQ34469221
Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studiesQ34508706
Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: A meta-analysisQ34536586
Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetesQ35641724
Major lipids, apolipoproteins, and risk of vascular diseaseQ35771393
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusQ37141727
The independent relationship between triglycerides and coronary heart disease.Q37167521
Changes in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort studyQ37394438
Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort StudyQ37676788
Postprandial hypertriglyceridemia as a coronary risk factorQ38186473
Triglycerides and cardiovascular diseaseQ38240749
Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery DiseaseQ38597329
Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis.Q38650891
Diabetes and atherosclerosis: an epidemiologic viewQ39764302
Comparison of lipid parameters to predict cardiovascular events in Japanese mild-to-moderate hypercholesterolemic patients with and without type 2 diabetes: Subanalysis of the MEGA studyQ39923768
Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.Q39936875
PKC-theta knockout mice are protected from fat-induced insulin resistanceQ39989111
Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.Q40452210
Relationship of an abnormal plasma lipoprotein to protection from atherosclerosis in the cholesterol-fed diabetic rabbitQ40682304
Relationship of Insulin Resistance to Prevalence and Progression of Coronary Artery Calcification Beyond Metabolic Syndrome Components: Shiga Epidemiological Study of Subclinical Atherosclerosis.Q40708983
Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults.Q41497141
Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemiaQ42278957
Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional studyQ42284569
Insulin inhibits migration of vascular smooth muscle cells with inducible nitric oxide synthaseQ42482576
Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosisQ43277564
Predictors of macrovascular disease in patients with type 2 diabetes mellitusQ43667342
Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and deathQ44024465
Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring studyQ44081087
Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart studyQ44262705
Hypertriglyceridemia as a cardiovascular risk factorQ44268486
Meta-analysis for trend estimationQ44706245
The triglyceride issue: a view from FraminghamQ44822390
LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.Q46942263
Triglyceride-lowering trialsQ47906559
Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China.Q48327312
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 IndividualsQ48517326
Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and DiseaseQ50118982
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.Q51005333
The relationship of serum lipoproteins to atherosclerosis in the cholesterol-fed alloxanized rabbit.Q51046355
Association between triglyceride glucose index and arterial stiffness in Korean adults.Q51244744
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.Q51355736
Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo.Q51625510
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and byQ55037836
Serum triglycerides predict first cardiovascular events in diabetic patients with hypercholesterolemia and retinopathyQ57166661
Triglycerides and the Risk of Coronary Heart DiseaseQ57267183
Effects of n-3 Fatty Acid Supplements in Diabetes MellitusQ57452493
High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular RiskQ58130023
Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaQ58480971
Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?Q58699954
Cause-specific mortality in a population-based study of diabetesQ68059236
Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wallQ68446303
Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilitiesQ68771667
Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative studyQ70460109
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia ManagementQ89216504
Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in ChinaQ90210774
Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination SurveyQ90804700
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectsystematic reviewQ1504425
type 2 diabetesQ3025883
P304page(s)48
P577publication date2019-04-15
P1433published inCardiovascular DiabetologyQ2468083
P1476titleSerum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies
P478volume18

Reverse relations

cites work (P2860)
Q90364685Could remnant-like particle cholesterol become a risk factor in diabetic menopausal women with coronary artery disease? A cross-sectional study of single academic center in China
Q91867947Triglyceride Level Is an Independent Risk Factor in First-Attacked Neuromyelitis Optica Spectrum Disorders Patients

Search more.